... its monoclonal antibody alirocumab for lowering cholesterol from concept to clinical trials in just 19 months. The Tarrytown, New York-based biotechnology firm has made its reputation on innovations that bust the bottlenecks of drug discovery and ...
http://sciencecareers.sciencemag.org/career_magazine/previous_issues/articles/2013_10_25/science.opms.r1300137
http://sciencecareers.sciencemag.org/career_magazine/previous_issues/articles/2013_10_25/science.opms.r1300137
No comments:
Post a Comment